Abstract
The aim of this study was to prepare cyclosporin A-loaded liposome (CyA-Lip) as an oral delivery carrier, with their encapsulation into microspheres based on alginate or extracellular polysaccharide (EPS) p-m 10356. The main advantage of liposomes in the microspheres (LIMs) is to improve the restricted drug release property from liposomes and their stability in the stomach environment. Alginate microspheres containing CyA-Lip were prepared with a spray nozzle; CyA-Liploaded EPS microspheres were also prepared using a w/o emulsion method. The shape of the LIMs was spherical and uniform, and the particle size of the alginate-LIMs ranged from 5 to 10 μm, and that of the EPS-LIMs was about 100 μm. In a release test, release rate of CyA in simulated intestinal fluid (SIF) from the LIMs was significantly enhanced compared to that in simulated gastric fluid (SGF). In addition, the CyA release rates were slower from formulations containing the liposomes compared to the microspheres without the liposome. Therefore, alginate-and EPS-LIMs have the potential for the controlled release of CyA and as an oral delivery system.
Similar content being viewed by others
References
O'Driscoll, C. M. (2002) Lipid-based formulations for intestinal lymphatic delivery.Eur. J. Pharm. Sci. 15: 405–415.
Charman, W. N. and C. J. H. Porter (1996) Lipophilic prodrugs designed for intestinal lymphatic transport.Adv. Drug Deliv. Rev. 19: 149–169.
Boinpally, R. R., S. L. Zhou, G. Devraj, P. K. Anne, S. Poondru, and B. R. Jasti (2004) Iontophoresis of lecithin vesicles of cyclosporin A.Int. J. Pharm. 274: 185–190.
Murdan, S., T. Andrysek, and D. Son (2005) Novel gels and their dispersions-oral drug delivery systems for ciclosporin.Int. J. Pharm. 300: 113–124.
Odeberg, J. M., P. Kaufmann, K. G. Kroon, and P. Hoglund (2003) Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine.Eur. J. Pharm. Sci. 20: 375–382.
Lee, C. M., D. W. Kim, H. C. Lee, and K. Y. Lee (2004) Peetin microspheres for oral colon delivery: preparation using spray drying method andin vitro release of indomethacin.Biotechnol. Bioprocess Eng. 9: 191–195.
Lee, C. M., S. Lim, G. Y. Kim, D. Kim, D. W. Kim, H. C. Lee, and K. Y. Lee (2004) Rosin microparticles as drug carriers: influence of various solvents on the formation of particles and sustained-release of indomethacin.Biotechnol. Bioprocess Eng. 9: 476–481.
Feng, S. S., G. Ruan, and Q. T. Li (2004) Fabrication and characterization of a novel drug delivery device liposomesin-microsphere (LIM).Biomaterials 25: 5181–5189.
Porter, C. J. H. and W. N. Charman (1997) Uptake of drugs into the intestinal lymphatics after oral administration.Adv. Drug. Deliv. Rev. 25: 71–89.
Fielding, R. M. (1991) Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective.Clin. Pharmacokinet. 21: 155–164.
Ribeiro, A. J., R. J. Neufeld, P. Armaud, and J. C. Chaumeil (1999) Microencapsulation of lipophilic drugs in chitosan-coated alginate microspheres.Int. J. Pharm. 187: 115–123.
Dai, C., B. Wang, H. Zhao, B. Li, and J. Wang (2006) Preparation and characterization of liposomes-in-alginate (LIA) for protein delivery system.Colloids Surf. B Biointerfaces 47: 205–210.
Crosasso, P., M. Ceruti, P. Brusa, S. Arpicco, F. Dosio, and L. Cattel (2000) Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.J. Control. Release 63: 19–30.
Zheng, C. H., J. O. Gao, Y. P. Zhang, and W. Q. Liang (2004) A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.Biochem. Biophys. Res. Commun. 323: 1321–1327.
Rothkopf, C., A. Fahr, G. Fricker, G. L. Scherphof and J. A. A. M. Kamps (2005) Uptake of phosphatidylserine-containing liposomes by liver sinusoidal endothelial cells in the serum-free perfused rat liver.Biochim. Biophys. Acta 1668: 10–16.
Lee, C. M., H. C. Lee, and K. Y. Lee (2005)O-palmitoylcurdlan sulfate (OPCurS)-coated liposomes for oral drug delivery.J. Biosci. Bioeng. 100: 255–259.
Kim, H. J., C. M. Lee, Y. B. Lee, and K. Y. Lee (2005) Preparation and mucoadhesive test of CSA-loaded liposomes with different characteristics for the intestinal lymphatic delivery.Biotechnol. Bioprocess Eng. 10: 516–521.
Iwanaga, K., S. Ono, K. Narioka, M. Kakemi, K. Morimoto, S. Yamashita, Y. Namba, and N. Oku (1999) Application of surface-coated liposomes for oral delivery of peptide: Effects of coating the liposome's surface on the GI transit of insulin.J. Pharm. Sci. 88: 248–252.
Moribe, K., E. Tanaka, K. Maruyama, and M. Iwatsuru (1998) Enhanced encapsulation of amphotericin B into liposomes by complex formation with polyethylene glycol derivatives.Pharm. Res. 15: 1737–1742.
Ferreira Almeida, P. and A. J. Almeida (2004) Cross-linked alginate-gelatine beads: a new matrix for controlled release of pindolol.J. Control. Release 97: 431–439.
Yoshikawa, H. (1997) Lymphatic delivery in ‘rectal drug delivery systems’.Adv. Drug Deliv. Rev. 28: 239–251.
Author information
Authors and Affiliations
Corresponding author
Additional information
Hee-Jung Park and Chang-Moon Lee were contributed equally to this work.
Rights and permissions
About this article
Cite this article
Park, HJ., Lee, CM., Lee, YB. et al. Controlled release of cyclosporin A from liposomes-in-microspheres as an oral delivery system. Biotechnol Bioproc E 11, 526–529 (2006). https://doi.org/10.1007/BF02932078
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02932078